Danish Synthetic Biology Drug Developer Octarine and British Clinical Research Organisation Clerkenwell Health Partner to Bring Innovative Psychedelics to Patients
This Copenhagen-based company is making psilocybin out of sugar!
Octarine Bio developed an innovative process of producing psilocybin from sugar using yeast fermentation. Not only is the process IP-protected, but its also low cost, sustainable, easily scalable, and has a stable supply chain.
This week, Octarine Bio partnered with a British clinical research organization, Clerkenwell Health, to advance human clinical trials and expand patient access to psychedelic therapy in Europe.